Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ischemic Heart Disease

  Free Subscription


04.05.2025

1 AJR Am J Roentgenol
2 Am Heart J
2 Am J Cardiol
1 Am J Emerg Med
1 Am J Med
1 Ann Thorac Surg
3 Atherosclerosis
2 BMJ
1 Can J Cardiol
1 Cardiovasc Res
1 Catheter Cardiovasc Interv
2 Circ Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
1 Circ Res
6 Circulation
3 Eur Heart J
9 Int J Cardiol
2 J Am Coll Cardiol
2 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Clin Invest
1 J Nucl Med
1 J Thorac Cardiovasc Surg
1 J Thromb Haemost
4 Lancet
1 Mol Cell Biochem
1 N Engl J Med
1 PLoS One
1 Prog Cardiovasc Dis
1 Thromb Haemost


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. JONAS RA, Nurmohamed NS, Crabtree TR, Aquino M, et al
    CTA-Derived Plaque Characteristics and Risk of Acute Coronary Syndrome in Patients With Coronary Artery Calcium Score of Zero: Insights From the ICONIC Trial.
    AJR Am J Roentgenol. 2025 Apr 30. doi: 10.2214/AJR.24.31476.
    PubMed         Abstract available


    Am Heart J

  2. BERGER JS, Lyu C, Iturrate E, Westerhoff M, et al
    Opportunistic Assessment of Abdominal Aortic Calcification using Artificial Intelligence (AI) Predicts Coronary Artery Disease and Cardiovascular Events.
    Am Heart J. 2025 Apr 24:S0002-8703(25)00137-1. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available

  3. SOH CH, Chen J, Marwick TH
    Incidence Rate of Coronary Atherosclerosis among Cancer Types during Survivorship: A Systematic Review and Meta-Analysis.
    Am Heart J. 2025 Apr 23:S0002-8703(25)00142-5. doi: 10.1016/j.ahj.2025.
    PubMed         Abstract available


    Am J Cardiol

  4. SUPPLES M, Smits S, Villenthi A, Snavely AC, et al
    Safety and Effectiveness of the High-Sensitivity HEART Pathway Safely Across Age Groups in Patients with Suspected Acute Coronary Syndrome.
    Am J Cardiol. 2025 Apr 25:S0002-9149(25)00277.
    PubMed         Abstract available

  5. XU Y, Ma J, He L, Zhang D, et al
    Predictors and Mechanisms of Non-culprit Plaque Progression in Patients with Acute Coronary Syndromes: An in-vivo Serial Optical Coherence Tomography Study.
    Am J Cardiol. 2025 Apr 23:S0002-9149(25)00278.
    PubMed         Abstract available


    Am J Emerg Med

  6. VERMA A, Jaiswal S, Gupta S, Mittal N, et al
    Association of vitamin B12 deficiency and hyperhomocystinemia with acute coronary syndromes - A case series.
    Am J Emerg Med. 2025 Apr 28:S0735-6757(25)00308.
    PubMed         Abstract available


    Am J Med

  7. POLLMANN DL, Knott JD, Carvalho PEP, Apple FS, et al
    Cardiac biomarkers for the prediction, discrimination, and risk-stratification of type 2 myocardial infarction: a critical appraisal.
    Am J Med. 2025 Apr 26:S0002-9343(25)00239-6. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available


    Ann Thorac Surg

  8. SONG S, Han X, Ma X, Wang X, et al
    Impact of Myocardial Hibernation and Scar on Benefits From CABG in Ischemic Left Ventricular Dysfunction.
    Ann Thorac Surg. 2025;119:1001-1010.
    PubMed         Abstract available


    Atherosclerosis

  9. TADA H, Nohara A, Usui S, Sakata K, et al
    Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.
    Atherosclerosis. 2025;404:119185.
    PubMed         Abstract available

  10. CONTE E, Lee SE, Chang HJ, Hadamitzky M, et al
    Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study.
    Atherosclerosis. 2025;404:119184.
    PubMed         Abstract available

  11. SUZUKI T, Haberlen S, Peterson TE, Palella F, et al
    Coronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study.
    Atherosclerosis. 2025;404:119181.
    PubMed         Abstract available


    BMJ

  12. JIANG H
    No-touch vein harvesting in coronary artery bypass surgery.
    BMJ. 2025;389:r728.
    PubMed        

  13. TIAN M, Wang X, Feng W, Wang H, et al
    No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2025;389:e082883.
    PubMed         Abstract available


    Can J Cardiol

  14. MATTIUZZI C, Lippi G
    Mortality Risk of Acute Myocardial Infarction and Acute Myocarditis in COVID-19 and Influenza: A U.S. Nationwide Analysis Using Death Certificates.
    Can J Cardiol. 2025 Apr 29:S0828-282X(25)00327.
    PubMed        


    Cardiovasc Res

  15. AHMAD H, Gopakumar J, Nachun DC, Ma L, et al
    Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue.
    Cardiovasc Res. 2025;121:396-404.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  16. XU H, Wang Z, Chen D, Zhang H, et al
    PCSK-9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST-Elevation Myocardial Infarction Patients With Chronic Kidney Disease.
    Catheter Cardiovasc Interv. 2025 Apr 25. doi: 10.1002/ccd.31543.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  17. STEIN E, Doll JA
    Response by Stein and Doll to Letter Regarding Article, "Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention".
    Circ Cardiovasc Interv. 2025 Apr 28:e015351.
    PubMed        

  18. ANG DTY, Collison D, McGeoch RJ, Carrick D, et al
    Novel Contrast-Derived Indices of Coronary Microvascular Function: Potential Clinical and Cost Benefits.
    Circ Cardiovasc Interv. 2025 May 1:e015058.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  19. FRAVEL MA, Ernst ME, Woods RL, Orchard SG, et al
    Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults.
    Circ Cardiovasc Qual Outcomes. 2025 Apr 28:e011719.
    PubMed         Abstract available

  20. WILLIAMS MS, Levine GN, Kalra D, Agarwala A, et al
    2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
    Circ Cardiovasc Qual Outcomes. 2025 Apr 30:e000140.
    PubMed         Abstract available


    Circ Res

  21. LIAO K, Yu J, Mohammadigoldar Z, Li J, et al
    Heart-Brain Crosstalk in Myocardial Infarction: Role of Heart Extracellular Vesicles in Neuroinflammation.
    Circ Res. 2025 May 1. doi: 10.1161/CIRCRESAHA.125.326237.
    PubMed        


    Circulation

  22. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    PubMed        

  23. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    PubMed        

  24. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    PubMed        

  25. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    PubMed         Abstract available

  26. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    PubMed         Abstract available

  27. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    PubMed         Abstract available


    Eur Heart J

  28. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    PubMed         Abstract available

  29. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
    Mosaic loss of Y chromosome and mortality after coronary angiography.
    Eur Heart J. 2025;46:1603-1616.
    PubMed         Abstract available

  30. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed         Abstract available


    Int J Cardiol

  31. LI Z, Huang S, Li H, Liu Q, et al
    PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport.
    Int J Cardiol. 2025;431:133222.
    PubMed         Abstract available

  32. YAMAMOTO K, Saito Y, Tateishi K, Kato K, et al
    Relation between previously implanted coronary stents and vasospasm: Patient- and vessel-level analysis.
    Int J Cardiol. 2025;431:133248.
    PubMed         Abstract available

  33. KUHN L, Akin I, Steinke P, Abumayyaleh M, et al
    Obesity is associated with impaired long-term prognosis in patients undergoing coronary angiography: Results from a large-scaled single centre registry.
    Int J Cardiol. 2025;431:133252.
    PubMed         Abstract available

  34. LAMMENS J, Motoc A, Tanaka K, Belsack D, et al
    Favorable impact of FFR(CT) on myocardial revascularization outcomes: Results from an observational real-world registry.
    Int J Cardiol. 2025;431:133245.
    PubMed         Abstract available

  35. DE GREGORIO C, Granata L, Raspanti D, Giannino F, et al
    Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights.
    Int J Cardiol. 2025;431:133249.
    PubMed         Abstract available

  36. SMARZ K, Tysarowski M, Ziolo J, Zaborska B, et al
    Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025;433:133320.
    PubMed         Abstract available

  37. PATTI G, Cumitini L, Bosco M, Marengo A, et al
    Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction.
    Int J Cardiol. 2025 Apr 29:133327. doi: 10.1016/j.ijcard.2025.133327.
    PubMed         Abstract available

  38. LIU T, Fan Z, Li Y, Xiao B, et al
    Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.
    Int J Cardiol. 2025;431:133229.
    PubMed         Abstract available

  39. WANG J, Li C, Zhang M, Zhou J, et al
    The performance of angiography-derived index of microcirculatory resistance for ischemia in angina with non-obstructive coronary artery disease: Validated by wire-based IMR and SPECT-MPI.
    Int J Cardiol. 2025;431:133236.
    PubMed         Abstract available


    J Am Coll Cardiol

  40. KRAMER CM
    My Fantastic Voyage: Innovation, Mentorship, and the Future of Cardiovascular Medicine.
    J Am Coll Cardiol. 2025 Apr 15:S0735-1097(25)06119.
    PubMed        

  41. WILLIAMS MS, Levine GN, Kalra D, Agarwala A, et al
    2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
    J Am Coll Cardiol. 2025 Apr 22:S0735-1097(25)00282.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  42. CAPPANNOLI L, Fracassi F, Aurigemma C, Romagnoli E, et al
    COLCHICINE IN ACUTE CORONARY SYNDROMES: A META-ANALYSIS OF 12.602 PATIENTS.
    J Cardiovasc Pharmacol. 2025 Apr 28. doi: 10.1097/FJC.0000000000001706.
    PubMed         Abstract available

  43. ZHANG C, Du Z, Chen R, Liu X, et al
    Gene- and cell-based therapy in cardiovascular diseases.
    J Cardiovasc Pharmacol. 2025 Apr 30. doi: 10.1097/FJC.0000000000001707.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  44. BJORNSDOTTIR S, Mannstadt M, Clarke B, Spelman T, et al
    Increased risk of cardiovascular diseases in patients with chronic hypoparathyroidism in Sweden.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf257. doi: 10.1210.
    PubMed         Abstract available


    J Clin Invest

  45. LIAO K, Yu J, Akhmerov A, Mohammadigoldar Z, et al
    Long noncoding RNA BCYRN1 promotes cardioprotection by enhancing human and murine regulatory T cell dynamics.
    J Clin Invest. 2025;135:e179262.
    PubMed         Abstract available


    J Nucl Med

  46. TRIVIERI MG, Devesa A, Robson PM, Bose S, et al
    Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients.
    J Nucl Med. 2025 Apr 30:jnumed.124.268980. doi: 10.2967/jnumed.124.268980.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  47. CHAE MC, Yoon S, Lee HJ, Jang WS, et al
    Outcomes of Ischemic Mitral Regurgitation after Coronary Revascularization Alone in Patients with Acute Coronary Syndrome.
    J Thorac Cardiovasc Surg. 2025 Apr 24:S0022-5223(25)00336.
    PubMed         Abstract available


    J Thromb Haemost

  48. ARIENS RA, McPherson HR, De Simone I, Huskens D, et al
    Length of ischaemia duration is associated with fibrin film coverage of acute myocardial infarction thrombi.
    J Thromb Haemost. 2025 Apr 24:S1538-7836(25)00266.
    PubMed         Abstract available


    Lancet

  49. GUO C, Shan D, Liu Z, He F, et al
    Ticagrelor monotherapy for acute coronary syndromes.
    Lancet. 2025;405:1461-1462.
    PubMed        

  50. APOSTOLOS A, Tsigkas G
    Ticagrelor monotherapy for acute coronary syndromes.
    Lancet. 2025;405:1462-1463.
    PubMed        

  51. VALGIMIGLI M, Hong SJ, Gragnano F, Hong MK, et al
    Ticagrelor monotherapy for acute coronary syndromes - Authors' reply.
    Lancet. 2025;405:1463-1464.
    PubMed        

  52. HUANG C
    Ticagrelor monotherapy for acute coronary syndromes.
    Lancet. 2025;405:1463.
    PubMed        


    Mol Cell Biochem

  53. YAO Y, Yu Y, Xu Y, Liu Y, et al
    Enhancing cardiac regeneration: direct reprogramming of fibroblasts into myocardial-like cells using extracellular vesicles secreted by cardiomyocytes.
    Mol Cell Biochem. 2025;480:3185-3200.
    PubMed         Abstract available


    N Engl J Med

  54. RADER DJ
    Targeting Lipoprotein(a) - the Next Frontier in Cardiovascular Disease.
    N Engl J Med. 2025;392:1740-1742.
    PubMed        


    PLoS One

  55. WANG D, Lai S, Wang Z, Xuan C, et al
    Impact of PCI strategies on outcomes of patients undergoing Transcatheter Aortic Valve Implantation with concomitant coronary artery disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321395.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  56. LORENZATTI D, Motwani M
    Cardiovascular magnetic resonance in pulmonary hypertension: Keeping it simple.
    Prog Cardiovasc Dis. 2025 Apr 26:S0033-0620(25)00064.
    PubMed        


    Thromb Haemost

  57. SPAGNOLO M, Capodanno D
    Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?
    Thromb Haemost. 2025 Apr 25. doi: 10.1055/a-2593-1763.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.